Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors
Cong Zeng, John P. Evans, Rebecca M. Pearson, et al.
JCI Insight (2020) Vol. 5, Iss. 22
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
Jinyi Tang, Cong Zeng, Thomas M Cox, et al.
Science Immunology (2022) Vol. 7, Iss. 76
Open Access | Times Cited: 262
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
Panke Qu, John P. Evans, Julia N. Faraone, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 1, pp. 9-17.e3
Open Access | Times Cited: 239
SARS-CoV-2 spreads through cell-to-cell transmission
Cong Zeng, John P. Evans, Tiffany King, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 119, Iss. 1
Open Access | Times Cited: 201
Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection
John P. Evans, Cong Zeng, Claire Carlin, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 637
Open Access | Times Cited: 201
Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
Panke Qu, Julia N. Faraone, John P. Evans, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 26, pp. 2526-2528
Open Access | Times Cited: 170
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
Kanika Vanshylla, Veronica Di Cristanziano, Franziska Kleipass, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 6, pp. 917-929.e4
Open Access | Times Cited: 156
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants
Panke Qu, Julia N. Faraone, John P. Evans, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112443-112443
Open Access | Times Cited: 144
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
Natalie Yan‐Lin Pang, Alexander Shao‐Rong Pang, Vincent Chow, et al.
Military Medical Research (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 132
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
John P. Evans, Cong Zeng, Panke Qu, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 8, pp. 1093-1102.e3
Open Access | Times Cited: 128
Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant
Panke Qu, John P. Evans, Yi-Min Zheng, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 11, pp. 1518-1526.e4
Open Access | Times Cited: 90
Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
Panke Qu, John P. Evans, Julia N. Faraone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 80
Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3
Julia N. Faraone, Panke Qu, Negin Goodarzi, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 68
Extraordinary Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants
Panke Qu, Julia N. Faraone, John P. Evans, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 42
Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114520-114520
Open Access | Times Cited: 27
Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion
Pei Li, Yajie Liu, Julia N. Faraone, et al.
mBio (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 26
Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 17
Neutralization and Stability of SARS-CoV-2 Omicron Variant
Cong Zeng, John P. Evans, Panke Qu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 96
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test
Antonin Bal, Bruno Pozzetto, Mary‐Anne Trabaud, et al.
Clinical Chemistry (2021) Vol. 67, Iss. 5, pp. 742-752
Open Access | Times Cited: 82
A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence
Xianwen Zhang, Yang Liu, Jianying Liu, et al.
Cell (2021) Vol. 184, Iss. 8, pp. 2229-2238.e13
Open Access | Times Cited: 73
COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer
Cong Zeng, John P. Evans, Karthik Chakravarthy, et al.
Cancer Cell (2021) Vol. 40, Iss. 2, pp. 117-119
Open Access | Times Cited: 69
Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection
Zhifen Cui, Cong Zeng, Furong Huang, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 10, pp. 1056-1064
Open Access | Times Cited: 45
Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants
Panke Qu, John P. Evans, Chaitanya Kurhade, et al.
mBio (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Neutralization escape of Omicron XBB, BR.2, and BA.2.3.20 subvariants
Julia N. Faraone, Panke Qu, John P. Evans, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 5, pp. 101049-101049
Open Access | Times Cited: 23
Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Viral infection neutralization tests: A focus on severe acute respiratory syndrome‐coronavirus‐2 with implications for convalescent plasma therapy
Daniele Focosi, Fabrizio Maggi, Paola Mazzetti, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 2
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top